Watanabe J et al. |
Safety Evaluation of Trastuzumab Emtansine in Japanese Patients with HER2-Positive Advanced Breast Cancer. |
|
In Vivo |
pmid:28438884
|
Yardley DA et al. |
Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Metastatic Breast Cancer Previously Treated With Chemotherapy and 2 or More HER2-Targeted Agents: Results From the T-PAS Expanded Access Study. |
|
Cancer J |
pmid:26389758
|
Muzaffar M et al. |
Acute Pancreatitis Associated With Ado-Trastuzumab Emtansine. |
|
Am J Ther |
pmid:25756468
|
|
|
|
|
pmid:
|
Hanka LJ and Barnett MS |
Microbiological assays and bioautography of maytansine and its homologues. |
1974 |
Antimicrob. Agents Chemother. |
pmid:15825322
|
Mandelbaum-Shavit F et al. |
Binding of maytansine to rat brain tubulin. |
1976 |
Biochem. Biophys. Res. Commun. |
pmid:985482
|
Sieber SM et al. |
Pharmacology of antitumor agents from higher plants. |
1976 |
Cancer Treat Rep |
pmid:136296
|
Mugera GM and Ward JM |
Acute toxicity of maytansine in F344 rats. |
1977 |
Cancer Treat Rep |
pmid:563288
|
Bhattacharyya B and Wolff J |
Maytansine binding to the vinblastine sites of tubulin. |
1977 |
FEBS Lett. |
pmid:852577
|
Kupchan SM et al. |
The maytansinoids. Isolation, structural elucidation, and chemical interrelation of novel ansa macrolides. |
1977 |
J. Org. Chem. |
pmid:874612
|
Hull RN et al. |
Studies on tissue culture produced plasminogen activator. I. Preliminary observations and the enhancing effect of colchicine and other antimitotic agents. |
1977 |
Thromb. Res. |
pmid:18812
|
Wehrli W |
Ansamycins. Chemistry, biosynthesis and biological activity. |
1977 |
Top Curr Chem |
pmid:74108
|
Osieka R et al. |
Chemotherapy of human colon cancer xenografts in athymic nude mice. |
1977 |
Cancer |
pmid:144557
|
Wall ME and Wani MC |
Antineoplastic agents from plants. |
1977 |
Annu. Rev. Pharmacol. Toxicol. |
pmid:326159
|
Higashide E et al. |
Ansamitocin, a group of novel maytansinoid antibiotics with antitumour properties from Nocardia. |
1977 Dec 22-29 |
Nature |
pmid:593392
|
O'Connell MJ et al. |
Phase II trial of maytansine in patients with advanced colorectal carcinoma. |
1978 |
Cancer Treat Rep |
pmid:356981
|
Issell BF and Crooke ST |
Maytansine. |
1978 |
Cancer Treat. Rev. |
pmid:367597
|
Kupchan SM et al. |
Structural requirements for antileukemic activity among the naturally occurring and semisynthetic maytansinoids. |
1978 |
J. Med. Chem. |
pmid:563462
|
Sieber SM et al. |
Teratogenic and cytogenetic effects of some plant-derived antitumor agents (vincristine, colchicine, maytansine, VP-16-213 and VM-26) in mice. |
1978 |
Teratology |
pmid:694777
|
Johnson RK et al. |
Stathmokinetic and therapeutic effects of maytansine in mice bearing P388 and L1210 leukemias. |
1978 |
Biochem. Pharmacol. |
pmid:708479
|
Eagan RT et al. |
Phase II evaluation of maytansine in patients with metastatic lung cancer. |
1978 |
Cancer Treat Rep |
pmid:709559
|
Alabaster O and Cassidy M |
Flow microfluorometric analysis of P388 murine leukemia after administration of vincristine and maytansine in vivo. |
1978 |
J. Natl. Cancer Inst. |
pmid:625068
|
Eagan RT et al. |
Early clinical study of an intermittent schedule for maytansine (NSC-153858): brief communication. |
1978 |
J. Natl. Cancer Inst. |
pmid:628025
|
Cabanillas F et al. |
Phase I study of maytansine using a 3-day schedule. |
1978 |
Cancer Treat Rep |
pmid:348310
|
Chabner BA et al. |
Initial clinical trials of maytansine, an antitumor plant alkaloid. |
1978 |
Cancer Treat Rep |
pmid:348311
|
Blum RH and Kahlert T |
Maytansine: a phase I study of an ansa macrolide with antitumor activity. |
1978 |
Cancer Treat Rep |
pmid:348312
|
Blum RH et al. |
A therapeutic trial of maytansine. |
1978 |
Cancer Clin Trials |
pmid:757139
|
Douros J and Suffness M |
New natural products of interest under development at the National Cancer Institute. |
1978 |
Cancer Chemother. Pharmacol. |
pmid:86390
|
Donoso JA et al. |
Maytansine action on fast axoplasmic transport and the ultrastructure of vagal axons. |
1978 |
Cancer Res. |
pmid:77186
|
Carter SK |
New drugs under clinical evaluation in the United States. |
1978 |
Cancer Chemother. Pharmacol. |
pmid:155503
|
Tanida S et al. |
Inhibition of cilia regeneration of Tetrahymena by ansamitocins, new antitumor antibiotics. |
1979 |
Antimicrob. Agents Chemother. |
pmid:475367
|
Rao PN et al. |
Cell cycle phase-specific cytotoxicity of the antitumor agent maytansine. |
1979 |
Cancer Res. |
pmid:455300
|
Cabanillas F et al. |
Results of a phase II study of maytansine in patients with breast carcinoma and melanoma. |
1979 |
Cancer Treat Rep |
pmid:371803
|
Ghetti B |
Induction of neurofibrillary degeneration following treatment with maytansine in vivo. |
1979 |
Brain Res. |
pmid:581857
|
Maslin DN |
[Ansamycins]. |
1979 |
Antibiotiki |
pmid:37801
|
Aldrich CD |
Pleiotropic phenotype of cultured murine cells resistant to maytansine, vincristine, colchicine, and adriamycin. |
1979 |
J. Natl. Cancer Inst. |
pmid:224236
|
Chahinian AP et al. |
Phase I study of weekly maytansine given by iv bolus or 24-hour infusion. |
1979 Nov-Dec |
Cancer Treat Rep |
pmid:526928
|
Creagan ET et al. |
Phase II evaluation of maytansine in patients with advanced head and neck cancer. |
1979 Nov-Dec |
Cancer Treat Rep |
pmid:526939
|
Oki T |
Cytotoxic and antitumor antibiotics produced by microorganisms. |
1980 |
Biotechnol. Bioeng. |
pmid:6159010
|
Ootsu K et al. |
Effects of new antimitotic antibiotics, ansamitocins, on the growth of murine tumors in vivo and on the assembly of microtubules in vitro. |
1980 |
Cancer Res. |
pmid:6245801
|
Tanida S et al. |
Ansamitocin-induced synchrony in Tetrahymena pyriformis. |
1980 |
J. Gen. Microbiol. |
pmid:6777454
|
Franklin R et al. |
A phase I-II study of maytansine utilizing a weekly schedule. |
1980 |
Cancer |
pmid:7214295
|
Jaffrey IS et al. |
Response to maytansine in a patient with malignant thymoma. |
1980 |
Cancer Treat Rep |
pmid:7379057
|
Tanida S et al. |
Ansamitocins, maytansinoid antitumor antibiotics. Producing organism, fermentation, and antimicrobial activities. |
1980 |
J. Antibiot. |
pmid:7380728
|
Kim SU et al. |
Neurofibrillary degeneration in cultured adult mouse neurons induced by maytansine. |
1980 |
Acta Neuropathol. |
pmid:7435167
|
Friedkin M and Rozengurt E |
The role of cytoplasmic microtubules in the regulation of the activity of peptide growth factors. |
1980 |
Adv. Enzyme Regul. |
pmid:7039258
|
Neidhart JA et al. |
Minimal single-agent activity of maytansine in refractory breast cancer: a Southwest Oncology Group study. |
1980 Apr-May |
Cancer Treat Rep |
pmid:7427953
|
Ahmann DL et al. |
Phase II study of maytansine and chlorozotocin in patients with disseminated malignant melanoma. |
1980 Apr-May |
Cancer Treat Rep |
pmid:6448689
|
Rosenthal S et al. |
Phase II study of maytansine in patients with advanced lymphomas: an Eastern Cooperative Oncology Group pilot study. |
1980 Oct-Nov |
Cancer Treat Rep |
pmid:7459897
|
Ikeyama S and Takeuchi M |
Antitubulin activities of ansamitocins and maytansinoids. |
1981 |
Biochem. Pharmacol. |
pmid:21043240
|